West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:03 20/09/2024 BST 5-day change 1st Jan Change
308.15 USD -0.98% Intraday chart for West Pharmaceutical Services, Inc. +2.49% -12.49%
LockThis article is reserved for members
To unlock the article, REGISTER!
Vous êtes déja client ? Log In
West Pharmaceutical Services, Inc. Presents at Bank of America Global Healthcare Conference 2024, Sep-18-2024 08:55 AM
West Pharmaceutical Services Insider Sold Shares Worth $308,700, According to a Recent SEC Filing MT
West Pharmaceutical Services Insider Sold Shares Worth $9,364,409, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $345 From $426 MT
UBS Adjusts West Pharmaceutical Services Price Target to $310 From $390, Maintains Neutral Rating MT
CJS Securities Adjusts Price Target on West Pharmaceutical Services to $350 From $380 MT
Deutsche Bank Adjusts Price Target on West Pharmaceutical Services to $265 From $355 MT
Stephens Adjusts Price Target on West Pharmaceutical Services to $340 From $400 MT
PCE data keeps Fed's rate cut dreams alive Our Logo
Analyst recommendations: Dexcom, Netflix, Tesla, Visa, Lululemon... Our Logo
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023. CI
Sector Update: Health Care Stocks Mixed Premarket Thursday MT
West Pharmaceutical Services, Inc., Q2 2024 Earnings Call, Jul 25, 2024
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data MT
West Pharmaceutical Q2 Adjusted Earnings, Revenue Fall; Trims FY24 Guidance; Shares Decline MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q2 EPS $1.52, vs. Street Est of $1.73 MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Stephens Adjusts Price Target on West Pharmaceutical Services to $400 From $420 MT
West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan MT
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell Midcap Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000 Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value-Defensive Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000E Value Index CI
West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing MT
Chart West Pharmaceutical Services, Inc.
More charts
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Employees
10,600
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
311.20USD
Average target price
351.85USD
Spread / Average Target
+13.06%
Consensus
  1. Stock Market
  2. Equities
  3. WST Stock
  4. News West Pharmaceutical Services, Inc.
  5. Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q2 EPS $1.52, vs. Street Est of $1.73
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW